CA
BSX icon

Clearstead Advisors’s Boston Scientific BSX Stock Holding History

Clearstead Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$565K Sell
13,244
-13,308
-50% -$723K 0.01% 717
2026
Q1 		$1.67M Buy
26,552
+6,066
+30% +$485K 0.02% 403
2025
Q4 		$1.95M Buy
20,486
+11,492
+128% +$1.13M 0.02% 334
2025
Q3 		$878K Sell
8,994
-2,966
-25% -$307K 0.01% 493
2025
Q2 		$1.28M Buy
11,960
+9,033
+309% +$914K 0.02% 389
2025
Q1 		$295K Buy
2,927
+620
+27% +$62.4K ﹤0.01% 717
2024
Q4 		$206K Sell
2,307
-54
-2% -$4.75K ﹤0.01% 846
2024
Q3 		$198K Buy
2,361
+67
+3% +$5.28K ﹤0.01% 865
2024
Q2 		$177K Buy
2,294
+444
+24% +$32.5K ﹤0.01% 853
2024
Q1 		$135K Sell
1,850
-16
-0.9% -$1.03K 0.01% 541
2023
Q4 		$108K Buy
1,866
+758
+68% +$40.5K 0.01% 570
2023
Q3 		$58.5K Buy
1,108
+254
+30% +$13.3K ﹤0.01% 666
2023
Q2 		$46.2K Hold
854
– – ﹤0.01% 739
2023
Q1 		$42.7K Buy
854
+195
+30% +$9.19K ﹤0.01% 698
2022
Q4 		$30.5K Buy
+659
New +$28.5K ﹤0.01% 723
2022
Q2 		– Sell
-77
Closed -$3K – 1291
2022
Q1 		$3K Buy
77
+6
+8% +$260 ﹤0.01% 1139
2021
Q4 		$3K Hold
71
– – ﹤0.01% 1054
2021
Q3 		$3K Sell
71
-125
-64% -$5.53K ﹤0.01% 1074
2021
Q2 		$8K Buy
+196
New +$8.25K ﹤0.01% 818

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clearstead Advisors's BSX Position: Q2 2026 in Review

Clearstead Advisors reduced its Boston Scientific (BSX) stake by 50% in Q2 2026, selling an estimated $723K and leaving 13,244 shares worth $565K. The position accounts for 0.01% of the portfolio, ranked #717.

Clearstead Advisors first reported a position in BSX in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.95M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clearstead Advisors held 13,244 shares of Boston Scientific worth $565K as of Q2 2026.
  • Clearstead Advisors sold 13,308 Boston Scientific shares in Q2 2026, an estimated $723K.
  • Boston Scientific made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #717 holding.
  • Clearstead Advisors first reported a position in Boston Scientific in Q2 2021 and has held it in 19 quarters since.
  • Clearstead Advisors's Boston Scientific position peaked at $1.95M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.